These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7920132)

  • 1. Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research.
    Smyth JF; Mossman J; Hall R; Hepburn S; Pinkerton R; Richards M; Thatcher N; Box J
    BMJ; 1994 Aug; 309(6952):457-61. PubMed ID: 7920132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Funding research and development in the NHS.
    Drummond MF; Crump BJ; Little VA
    Lancet; 1992 Jan; 339(8787):230-1. PubMed ID: 1346184
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer researchers say NHS reforms undermining trials.
    Dickson D
    Nature; 1994 Aug; 370(6490):499. PubMed ID: 8052299
    [No Abstract]   [Full Text] [Related]  

  • 4. Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002.
    Chalmers I; Rounding C; Lock K
    BMJ; 2003 Nov; 327(7422):1017. PubMed ID: 14593034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GP recruitment and retention: a qualitative analysis of doctors' comments about training for and working in general practice.
    Evans J; Lambert T; Goldacre M
    Occas Pap R Coll Gen Pract; 2002 Feb; (83):iii-vi, 1-33. PubMed ID: 12049026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The medical service increment for teaching (SIFT): a pound400m anachronism for the English NHS?
    Bevan G
    BMJ; 1999 Oct; 319(7214):908-11. PubMed ID: 10506054
    [No Abstract]   [Full Text] [Related]  

  • 7. Health economics and quality of life in cancer trials: report based on a UKCCCR workshop. United Kingdom Coordinating Committee on Cancer Research.
    Fitzpatrick R; Davies L
    Br J Cancer; 1998 May; 77(10):1543-8. PubMed ID: 9635826
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary Care Research Team Assessment (PCRTA): development and evaluation.
    Carter YH; Shaw S; Macfarlane F
    Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Academic medicine: time for reinvention: MRC aims to give NHS evidence from randomised clinical trials.
    Blakemore C; Chalmers I
    BMJ; 2004 Jan; 328(7430):49; discussion 49. PubMed ID: 14703562
    [No Abstract]   [Full Text] [Related]  

  • 10. Staffing costs in primary health care.
    Saint-Yves IF
    J R Soc Health; 1984 Jun; 104(3):108-10. PubMed ID: 6431094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Health Service funding for complementary medicine research: the NHS acupuncture trials.
    Vickers A
    Complement Ther Med; 1999 Mar; 7(1):1-2. PubMed ID: 10361565
    [No Abstract]   [Full Text] [Related]  

  • 12. Funding the NHS. A little local difficulty?
    Dixon J; Harrison A
    BMJ; 1997 Jan; 314(7075):216-9. PubMed ID: 9022445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teaching and research in hospitals: implications for the NHS reforms.
    Farrar S; Donaldson C
    Health Policy; 1993 Sep; 25(1-2):141-51. PubMed ID: 10129154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. King's model for allocating service increment for teaching and research (SIFTR).
    Clack GB; Bevan G; Peters TJ; Eddleston AL
    BMJ; 1992 Jul; 305(6845):95-6. PubMed ID: 1638254
    [No Abstract]   [Full Text] [Related]  

  • 15. Research funds for complementary medicine.
    Chen HY; Ma BY; Grant A
    Lancet; 2001 Jun; 357(9272):1982. PubMed ID: 11436226
    [No Abstract]   [Full Text] [Related]  

  • 16. Service increment for teaching and research (SIFTR): the Southampton experience.
    Smith CL
    BMJ; 1992 Jul; 305(6845):97-8. PubMed ID: 1342782
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Government funding of the UK National Health Service: what does the historical record reveal?
    Appleby J
    J Health Serv Res Policy; 1999 Apr; 4(2):79-89. PubMed ID: 10387411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. US government is funding fewer trials as number of industry sponsored trials grows.
    Dyer O
    BMJ; 2015 Dec; 351():h6893. PubMed ID: 26684014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.